NAD+ anti-aging trend faces fierce debate over science versus illusion

From Hollywood stars to wellness influencers, NAD+ has exploded into the ultimate anti-ageing trend, yet a fierce debate rages over whether it truly slows the clock or merely fuels a lucrative illusion. Celebrities like Hailey Bieber, who jokingly declared on *The Kardashians* that she intends to "NAD for the rest of my life," have normalized the practice, joining figures like Gwyneth Paltrow and Jennifer Aniston in promoting intravenous wellness treatments. Now, the molecule nicotinamide adenine dinucleotide is being sold everywhere from high-end clinics to mail-order kits, promising everything from sharper minds to stronger immunity and a literal reversal of aging.

The science behind the hype is complicated. NAD+ is a vital molecule found in every living cell, essential for converting food into energy and repairing DNA. As humans age, natural NAD+ levels drop. Dr Michael Sagner, a clinical adviser at King's College London specializing in longevity, explains the basic logic: "The assumption was that if we stop this decline, or if we somehow managed to increase energy levels, that we could slow down ageing." This biological fact has created a booming market where a single hour-long IV drip can cost up to £400, and at-home injection kits run roughly £350 for a month-long course. Pills, powders, and patches are priced between £20 and £80 or more, with the broader sector now valued in the billions.

However, experts warn that this market has raced far ahead of the science. Dr Sagner argues that while the concept sounds logical, the evidence in healthy humans remains woefully limited. "It's extremely difficult to do these trials because you'd have to have thousands of patients, and make sure they take it every day," he noted. Measuring life extension in humans with lifespans of 80 years is practically impossible compared to animal studies where lifespans are just a few years. Consequently, any claims that NAD+ products can extend life or reverse aging in healthy people are largely unproven and based mainly on animal research.

Despite the skepticism, some practitioners insist they have seen real benefits. Dr Enayat claims his patients have experienced positive results, particularly regarding fatigue, brain fog, and poor sleep. Yet, the regulatory landscape is murky, with products ranging from poorly regulated supplements to expensive medical procedures. While promising disease-specific studies exist for conditions like Parkinson's and cardiovascular disease, these do not translate to keeping healthy people young. As the industry forecasts sharp growth, the public faces a critical question: are they investing in a scientific breakthrough or simply paying a premium for a fashionable placebo?

The prevailing medical philosophy is increasingly focused on extending the duration of a disease-free state as individuals age. However, a significant controversy has emerged surrounding the surging popularity of NAD+ intravenous drips, which inject the compound directly into the bloodstream. Dr Sagner has characterized significant segments of this industry as opaque and existing within a "very grey market." He noted that operations in underground clinics across London and other locations often proceed in secrecy.

According to Dr Sagner, some of these illicit providers have been known to remove NAD+ from their formulations entirely, yet continue to charge patients for the treatment while administering small quantities of vitamin C or other substances to mitigate side effects, all in pursuit of profit. He issued a stark warning that these clinics pose severe dangers. The procedures have already resulted in documented adverse reactions, including inflammation, allergic responses, headaches, and dizziness. While verifying every report of serious complications remains difficult for the public, the risks associated with intravenous administration are clear.

Dr Sagner explained the biological rationale behind the danger: the human body is engineered to synthesize NAD+ internally within cells using precursor compounds, not to receive it directly via the bloodstream. "Your body doesn't want it in the bloodstream," he stated. The only scientifically sensible method to elevate NAD+ levels is through oral intake of nicotinamide riboside (NR). He clarified that even oral NR is a small molecule that must be broken down by the body to enter cells; introducing high concentrations of NAD+ directly into the blood triggers an inflammatory response because the substance belongs strictly inside the cell.

The two primary precursors available for supplementation are NR and nicotinamide mononucleotide (NMN). While these are sold as dietary supplements intended to provide the raw materials for the body to manufacture its own NAD+, Dr Sagner cautioned consumers regarding the lack of uniform regulation. In the UK, products marketed without medicinal claims are classified as food supplements rather than medicines, meaning they bypass the rigorous efficacy assessments conducted by the MHRA for licensed drugs. Although some manufacturers adhere to recognized quality standards, many IV drips, powders, patches, and at-home kits lack proper testing, leaving consumers unsure of their origin or safety.

Dr Sagner expressed particular skepticism regarding NAD+ patches, dismissing them as nonsensical. Beyond regulatory issues, there is a profound theoretical concern regarding the unintended consequences of artificially elevating NAD+ levels indefinitely. He warned that endlessly boosting NAD+ could potentially increase the risk of cancer. Although no human studies have yet proven that NAD+ supplements cause cancer, scientists have raised alarms because NAD+ plays a critical role in cellular energy production and DNA repair—processes that are also essential for the survival and growth of cancer cells. Furthermore, there may be other metabolic downsides to attempting to hyper-activate cells through such interventions.

Dr Sagner warned that enhancing cellular energy pathways inevitably increases biological waste, forcing the body to clear more by-products.

He explained that boosting any process designed to generate extra energy simultaneously produces a corresponding rise in metabolic refuse.

This trade-off suggests that pushing cells to run faster might create a burden rather than a solution for the body.

Furthermore, Sagner noted that long-lived species like turtles and elephants typically possess slow metabolisms rather than rapid ones.

He concluded that the aging process is far too complex to be solved merely by accelerating cellular activity.

Conversely, Dr Enayat, a GP and founder of the longevity clinic HUM2N, argues that NAD+ offers tangible benefits to specific patients.

He reports seeing improvements in symptoms such as brain fog, fatigue, and disrupted sleep patterns among his clients.

Enayat maintains that the mechanism of delivery matters less than the visible clinical recovery experienced by his patients.

He stated, "I see my patients improve, clinically - and that's where I build my confidence with them."

He questioned why patients report better motivation if scientists insist the substance must enter the cell directly to work.

According to Enayat, approximately 75 per cent of his patients experience relief in energy, sleep, and mental clarity.

However, he cautioned against the widespread misrepresentation of NAD+ as a universal cure for every health issue.

He asserted that the substance is only necessary when levels are depleted, not as a magic transformation for everyone.

This pragmatic stance aligns with Dr Sagner's advice to verify low levels before pursuing supplementation or injections.

Sagner suggested that smart individuals should measure their NAD levels at a lab before taking any action.

He recommended treating low levels as a deficiency that oral supplements like NR can address within one or two weeks.

He added that adults over forty might try high-quality NR for three weeks to assess improvements in energy.

Despite these potential short-term gains, experts emphasize that proof for long-term anti-aging benefits remains entirely absent.

A representative for the MHRA confirmed that unregulated supplements fall outside their safety remit and lack medicinal claims.

They stated they cannot advise on the efficacy or safety of products that do not make medicinal assertions.

Consequently, specialists urge caution regarding NAD+ injections, especially for those with existing conditions or cancer histories.

While celebrities market NAD+ as a youth shortcut, medical consensus demands avoiding exaggerated claims and unregulated providers.

The realistic conclusion is that more is not always better and that patients should remain wary of oversold solutions.